InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,934.36
(
-0.63%
)
Post# of 648993
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jape1

Send PM Follow Ignore
Followers 13
Posts 686
Boards Moderated 0
Alias Born 01/09/2012

jape1

Re: TraderUsa post# 344812

Thursday, 05/07/2015 2:58:10 PM

Thursday, May 07, 2015 2:58:10 PM

Post# of 648993
Rumor has it that Merck is in discussion with Oxigene for the ovarian cancer drug. Expecting FDA announcement 6/30
I was on the cc and they said they will announce FDA news closer to end of Q2. 6/30. http://t.co/OIuVQRmaJ9

https://twitter.com/tiki473/status/596260727477968896

$OXGN
OXGN
Oxigene inc

Diversification is a symptom of weakness.
no decision, without knowledge and confidence in
oneself, NOTHING.

**make their own decisions, not those of anyone.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up